Is there a role for Desmopressin as an alternative to platelet transfusion prior to procedures or Radiological InterVEntions in thrombocytopenic critically ill patients (DRIVE)? Results of a randomised double-blind placebo-controlled feasibility trial
Desborough M., Laing E., Kounali D., Mora A., Hodge R., Martin S., Shah A., Parke T., Wise M., Morgan M., McKechnie S., Stanworth S., Investigators DRIVE.